This inventor holds 7 USPTO granted patents and 18 published patent applications. Top assignees: Innovative Cellular Therapeutics Holdings, Ltd., Innovative Cellular Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 31 
7 out of 15 Years Active: 2023-2026
Title: The Innovative Contributions of Le Tian in Cancer Treatment
Introduction
Le Tian, an accomplished inventor based in Rockville, MD, has made significant contributions to the field of cancer treatment through his innovative approaches. With a portfolio of three patents, his work focuses on developing advanced therapeutic methods for combating digestive system cancers.
Latest Patents
Le Tian's latest patents showcase his dedication to improving cancer therapies. The first patent, titled "Anti-GCC Antibody and CAR Thereof for Treating Digestive System Cancer," discloses various compositions and methods aimed at treating patients suffering from digestive tract cancers. This method involves administering a composition that includes a population of cells with chimeric antigen receptors (CAR) targeting specific antigens associated with white blood cells.
His second patent, "Nanobody Target GCC and Uses in Chimeric Antigen Receptor Cell Therapy," further elaborates on the application of CAR T therapy and antibodies that target the GCC antigen in solid tumors. The compositions detailed in this patent include CARs with an extracellular domain designed to bind GCC, laying the groundwork for potential breakthrough therapies.
Career Highlights
Le Tian has gained critical experience while working with reputable organizations such as Innovative Cellular Therapeutics Holdings and Innovative Cellular Therapeutics, Inc. His commitment to research and innovation has helped foster advancements in cellular therapies, pushing the boundaries of cancer treatment.
Collaborations
During his career, Le Tian has collaborated with notable colleagues, including Zhiyuan Cao and Lei Xiao. These partnerships have played a vital role in advancing his research and bringing innovative solutions to the forefront of cancer therapy.
Conclusion
Le Tian continues to pave the way for innovative cancer treatments through his groundbreaking patents and collaborative efforts. His work is essential in the ongoing battle against cancer, offering hope and improved treatment options for patients dealing with challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile